Found 32 matching trials
Multimodal Cue Exposure Therapy for Smoking Cessation
PHASE2At two sites (Boston University and the University of Texas at Austin, unde...
Location
Multiple Locations
Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
PHASE2This study is to assess the efficacy of bupropion in reducing methamphetami...
Location
UCLA Integrated Substance Abuse Program
A Trial of AXS-05 in Patients With Major Depressive Disorder
PHASE3A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial ...
Location
Clinical Research Site
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
PHASE3This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Pharmacologic Relapse Prevention for Alcoholic Smokers
PHASE2This study will compare the long-term use of bupropion (Wellbutrin) and pla...
Location
Mayo Clinic Rochester
Bupropion and Weight Control for Smoking Cessation - 1
PHASE4The purpose of this study is to determine whether the addition of bupropion...
Location
Western Psychiatric Institute & Clinic
Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya
PHASE3The proposed study will use a factorial design to evaluate the most promisi...
Location
Center for International Health, Education, and Biosecurity (CIHEB)
Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya
PHASE3People with HIV (PWH) smoke tobacco cigarettes and drink alcohol at higher ...
Location
Mathari National Teaching and Referral Hospital
A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression
EARLY_PHASE1Antidepressants is the primary treatment for depression, but only less than...
Location
The First Affiliated Hospital of Kunming Medical University
Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
PHASE3This study is designed to evaluate the efficacy and safety in depressive pa...
Location
GSK Investigational Site